Procalcitonina como biomarcador | 15 ABR 13

Tratamiento antibiótico guiado por la procalcitonina

Una nueva manera de reducir la indicación de antibióticos sería a través del uso de un biomarcador que aumente en presencia de infección bacteriana y se normalice después de que la infección haya sido tratada en forma adecuada
Autor/a: Dres. Tasaduq Fazili, Timothy Endy, Waleed Javaid, Mitu Maskey Am J Health-Syst Pharm. 2012; 69:2057-61
INDICE:  1. Artículo | 2. Referencias
Referencias

Referencias

1. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983;5:1033-48.
2. Shales DM, Gerding DN, John JF Jr et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of    America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997; 25:584-99.
3. Müller B, White J, Nylén E et al. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001; 86:396-404.
4. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 1998; 24:888-9.
5. Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis. 2011; 52(suppl 4):S346-50.
6. Assicot M, Gendrel D, Carsin H et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993; 341:515-8.
7. Müller B, Becker KL, Schächinger H et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000; 28:977-83.
8. Simon L, Gauvin F, Amre D et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Inf Dis. 2004; 39:206-17.
9. Briel M, Schuetz P, Mueller B et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008; 168:2000-7.
10. Burkhardt O, Ewig S, Haagen U et al. Procalcitonin guidance and reductions of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010; 36:601-7.
11. Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections. Lancet. 2004; 363:600-7.
12. Christ-Crain M, Stolz D, Bingisser R et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. Am J Crit Care Med. 2006; 174:84-93.
13. Stolz D, Christ-Crain M, Bingisser R et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007; 131:9-19.
14. Kristofferson KB, Sogaard OS, Wejse C et al. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission—a randomized trial. Clin Microbiol Infect. 2009; 15:481-7.
15. Schuetz P, Christ-Crain M, Thomann R et al. Effect of procalcitonin-based guidelines vs. standard guidelines on antibiotic use in lower respiratory tract infections. The ProHOSP randomized controlled trial. JAMA. 2009; 302:1059-66.
16. Nobre V, Harbarth S, Graf JD et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008; 177:498-505.
17. Stolz D, Smyrnios N, Eggimann P et al. Procalcitonin for reduced antibiotic exposure in ventilator associated pneumonia: a   randomized study. Eur Respir J. 2009; 34:1364-75.
18. Hochreiter M, Kohler T, Schweiger A et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009; 13:R83.
19. Schroeder S, Hochreiter M, Koehler T et al. Procalcitonin-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg. 2009; 394:221-6.
20. Bouadma L, Luyt CE, Tubach F et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010; 375:463-74.
21. Liew YX, Chlebicki MP, Lee W et al. Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP). Eur J Clin Microbiol Infect Dis. 2011; 30:853-5.
22. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011; 17(suppl 6):E1-59.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022